Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Brazilian (BOVESPA) Pharma Industry Analysis

UpdatedApr 03, 2026
DataAggregated Company Financials
Companies2
  • 7D3.3%
  • 3M0.3%
  • 1Y13.9%
  • YTDn/a

In the last week, Pharma has been flat. The past year has been better, since the industry has gained 14% in that time. Looking forward, earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the Brazilian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Apr 2026R$16.0bR$8.9bR$1.4b9.4x11.3x1.8x
Sun, 01 Mar 2026R$15.9bR$8.1bR$969.3m13.4x16.4x2x
Tue, 27 Jan 2026R$17.3bR$8.1bR$969.3m14.3x17.9x2.1x
Thu, 25 Dec 2025R$15.9bR$8.1bR$969.3m13.2x16.4x2x
Sat, 22 Nov 2025R$17.3bR$8.1bR$969.3m13.9x17.9x2.1x
Mon, 20 Oct 2025R$15.1bR$7.7bR$876.7m13.8x17.2x1.9x
Wed, 17 Sep 2025R$15.8bR$7.7bR$876.7m14.6x18.1x2x
Fri, 15 Aug 2025R$15.8bR$7.7bR$876.7m14.5x18x2x
Sun, 13 Jul 2025R$18.3bR$7.7bR$934.1m15.6x19.6x2.4x
Tue, 10 Jun 2025R$17.7bR$7.7bR$934.1m15.4x18.9x2.3x
Thu, 08 May 2025R$15.6bR$7.7bR$944.9m13.5x16.5x2x
Sat, 05 Apr 2025R$14.1bR$8.5bR$1.5b9.3x9.6x1.7x
Mon, 03 Mar 2025R$13.0bR$8.7bR$1.7b9.1x7.8x1.5x
Wed, 29 Jan 2025R$12.9bR$8.7bR$1.7b8.9x7.8x1.5x
Fri, 27 Dec 2024R$12.8bR$8.7bR$1.7b9.3x7.7x1.5x
Sun, 24 Nov 2024R$14.0bR$8.7bR$1.7b10.7x8.4x1.6x
Tue, 22 Oct 2024R$17.4bR$8.9bR$1.7b15.7x10x1.9x
Thu, 19 Sep 2024R$19.7bR$8.9bR$1.7b16.4x11.3x2.2x
Sat, 17 Aug 2024R$20.8bR$8.9bR$1.7b16.8x11.9x2.3x
Mon, 15 Jul 2024R$19.7bR$9.0bR$1.7b11x11.8x2.2x
Wed, 12 Jun 2024R$19.3bR$9.0bR$1.7b10.8x11.6x2.1x
Fri, 10 May 2024R$20.4bR$9.0bR$1.7b11.3x12.3x2.3x
Sun, 07 Apr 2024R$21.1bR$8.9bR$1.6b12x13.2x2.4x
Tue, 05 Mar 2024R$22.5bR$9.2bR$1.7b12x12.8x2.4x
Thu, 01 Feb 2024R$21.0bR$9.2bR$1.7b11.3x12x2.3x
Sat, 30 Dec 2023R$24.0bR$9.2bR$1.7b12.8x13.7x2.6x
Mon, 27 Nov 2023R$22.9bR$9.2bR$1.7b12.2x13.1x2.5x
Wed, 25 Oct 2023R$22.6bR$9.1bR$1.8b39.4x12.8x2.5x
Fri, 22 Sep 2023R$24.7bR$9.1bR$1.8b40.7x14.1x2.7x
Sun, 20 Aug 2023R$27.5bR$9.1bR$1.8b44x15.6x3x
Tue, 18 Jul 2023R$29.7bR$8.8bR$1.8b14.1x16.5x3.4x
Thu, 15 Jun 2023R$30.4bR$8.8bR$1.8b14.7x16.8x3.5x
Sat, 13 May 2023R$25.2bR$8.8bR$1.8b13x14x2.9x
Mon, 10 Apr 2023R$25.2bR$8.6bR$1.8b12.1x13.8x2.9x
Price to Earnings Ratio

13.8x


Total Market Cap: R$25.2bTotal Earnings: R$1.8bTotal Revenue: R$8.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Pharma Industry Price to Earnings3Y Average 13.7x202420252026
Current Industry PE
    There are only 2 companies in the Brazilian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 8.2% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Brazilian Pharma compare with similar industries?

BR Market3.43%
Healthcare5.17%
Pharma3.27%
Pharma3.27%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HYPE3 HyperaR$22.993.8%
+R$531.7m		13.1%PE12.2x

Latest News

HYPE3
R$22.99
Hypera
7D
3.8%
1Y
13.1%
OFSA3
R$27.55
Ouro Fino Saúde Animal Participações
7D
-1.6%
1Y
22.8%